3[2] Friend DR. Review article:Issues on oral administration of locall y acting glucocorticosteriods for treatment of inflammatory bowel disease[J]. Aliment Pharmacol Ther, 1998;12(7):591-603.
4[3] Mclead AD, Friend DR, Tozer TN. Synthesis and chemical stability of glucocorticoid-dextran esters:Potential prodrugs for colon-specific delive ry[J]. Inter J Pharm, 1993;92(2): 105-114.
5[4] Hanninen O, Lindstrom-Sppa P, Pelkonen K. Role of gut in xenobi otic metabolism[J]. Arch Toxico, 1987;60(1): 34-36.
6[5] Williams-Smiths.H Observations on the flora of the alimentary tr act of animals and factors affecting its composition[J]. J Phathol Bacteriol , 1965;89(2):95-122.
7[6] Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage for ms through the small intestine[J]. Gut, 1986;27(8):886-892.
8[7] Hardy JG,Wilson CG, Wood E. Drug delivery to the proximal colon[J ]. J Pharmacol, 1985;37(12):847-877.
9[1] Richard NF, Barbara H, Lonnie RE et al. Colonic deliver y of dexamet hasone from a prodrug accelerates healing of colitis in rats without adrenal sup pression[J]. Gastroenterology, 1995;108(6):1688-1699.
10[1]Sinha VR, Kumria R. Binders for colon specific drug delivery: an in vitro evaluation[J]. International Journal of Pharmaceutics, 2001, 249: 23-31
